Solid-phase extraction and gas chromatographic-mass spectrometric determination of the veterinary drug xylazine in human blood

Journal of Analytical Toxicology

Volumn 31, Issue 3, 2007, Pages 165-169

  Barroso, M ^a   Gallardo, E ^b   Margalho, C ^a   Devesa, N ^c   Pimentel, J ^c   Vieira, D N ^a  

^a INSTITUTO NACIONAL DE MEDICINA LEGAL E CIÊNCIAS FORENSES   (Portugal)

^b UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^c CENTRO HOSPITALAR E UNIVERSITÁRIO DE COIMBRA   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

PROTRIPTYLINE; XYLAZINE;

ACCURACY; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; GAS CHROMATOGRAPHY; HUMAN; INTOXICATION; MASS SPECTROMETRY; ROOM TEMPERATURE; SOLID PHASE EXTRACTION;

EID: 34247342184     PISSN: 01464760     EISSN: 01464760     Source Type: Journal    
DOI: 10.1093/jat/31.3.165     Document Type: Article

References (26)

1. G. Kroneberg, A. Oberdorf, F. Hoffmeister, and W. Wirth. On the pharmacology of 2-(2,6-dimethylphenylamino)-4H-5,6-dihydro-1,3-thiazine (Bayer 1470), a substance inhibitory for adrenergic and cholinergic neurons. Naunyn Schmiedebergs Arch. Exp. Pathol. Pharmakol. 256: 257-280 (1967).
2. R.E. Mittleman, W.L. Hearn, and G.W. Hime. Xylazine toxicity - literature review and report of two cases. J. Forensic Sci. 43: 400-402 (1998).
3. K. Parfitt. Martindale. The Complete Drug Reference, 32nd ed. Pharmaceutical Press, Tauton, MA, 1999, p 1645.
4. United States Department of Agriculture. Xylazine/Tolazolidone, www.ams.usda.gov/nop/NationalList/TAPReviews/Xylazineolazoline.pdf, January 2006.
5. K.A. Moore, M.G. Ripple, S. Sakinedzad, B. Levine, and D.R. Fowler. Tissue distribution of xylazine in a suicide by hanging. J. Anal. Toxicol. 27: 110-112 (2003).
6. J.J. Meana and J.A. Garcia-Sevilla. Transmisión catecolaminérgica. Fármacos agonistas catecolaminérgicos. In Farmacología Humana, 3rd ed., J. Flórez, Ed. Masson S.A., Barcelona, Spain, 1997, pp 235-260.
7. J.J. Fyffe. Effects of xylazine on humans: a review. Ast. Vet. J. 71: 294-295 (1994).
8. U. Hoffmann, C.M. Meister, K. Golle, and M. Zschiesche. Severe intoxication with the veterinary tranquilizer xylazine in humans. J. Anal. Toxicol. 25: 245-249 (2001).
9. World Health Organization and Food and Agriculture Organization. Xylazine INCHEM, www.inchem.org/documents/jecfa/jecmono/v38je03.htm, October 2005.
10. A.G. Gallanosa, D.A. Spyker, and D.L. Morris. Human xylazine overdose: a comparative review with clonidine, phenothiazines and tricyclic antidepressants. Clin. Toxicol. 18: 663-678 (1981).
11. W.A. Jensen. Yohimbine for treatment of xylazine overdose in a cat. J. Am. Vet. Med. Assoc. 187: 627-628 (1985).
12. D.G. Spoerke, A.H. Hall, M.J. Grimes, B.N. Honea, and B.H. Rumack. Human overdose with veterinary tranquilizer xylazine. Am. J. Emerg. Med. 4: 222-224 (1986).
13. A. Poklis, M.A. Mackell, and M. Case. Xylazine in human tissues and fluids in a case of fatal drug abuse. J. Anal. Toxicol. 9: 234-236 (1985).
14. M.E. Stillwell. A reported case involving impaired driving following self-administration of xylazine. Forensic Sci. Int. 134: 25-28 (2003).
15. I.R Miksa, M.R. Cummings, and R.H. Poppenga. Determination of acepromazine, ketamine, medetomidine, and xylazine in serum: multi-residue screening by liquid chromatography-mass spectrometry. J. Anal. Toxicol. 29: 544-551 (2005).
16. Food and Drug Administration: U.S. Department of Health and Human Services. Guidance for Industry, Bioanalytical Method Validation. FDA, www.fda.gov/cder/guidance/4252fnl.pdf, January 2003.
17. International Conference on Harmonization (ICH). Validation of Analytical Procedures: Methodology ICH Q2 B. ICH, www.ich.org/MediaServer.jser?@_ID= 4188@_MODE=GLB, January 2003.
18. R.C Baselt. Disposition of Toxic Drugs and Chemicals in Man, 7th ed. Biomedical Publications, Foster City, CA, 2004, pp 1197-1198.
19. J.I. Elejalde, C.J. Louis, R. Elecuaz, and M.A. Pinillos. Drug of abuse with inhalated xylazine. Eur. J. Emerg. Med. 10: 252-253 (2003).
20. F.O. Arican, T. Okan, O. Badak, and S. Guneri. An unusual presentation from xylazine-ketamine. Vet. Hum. Toxicol. 46: 324-325 (2004).
21. U.S. Drugs Enforcement Administration. Drugs of Abuse, www.dea.gov/pubs/abuse/doa-p.pdf, April 2006.
22. S.G. Carruthers, M. Nelson, H.R. Wexler, and C.R. Stiller. Xylazine hydrochloride (Rompum) overdose in man. Clin. Toxicol. 15: 281-285 (1979).
23. S. Lewis, C.L.P. O'Callagham, and P.J. Toghill. Clinical Curio: self medication with xylazine. Br. Med. J. 287: 1369 (1983).
24. A. Samanta, C. Roffe, and K.L. Woods. Accidental self administration of xylazine in a veterinary nurse. Postgrad. Med. J. 66: 244-245 (1990).
25. Th.A. Briellmann, R. Rickli, and C. Jenny. A fatal intoxication with xylazine. TIAFT Bull. Case Notes, 24, 1994.
26. A.J. Capraro, J.F. Wiley, II, and J.R. Tucker. Severe intoxication from xylazine inhalation. Pediatr. Emerg. Care 17: 447-448 (2001).